Zelluna ASA Company Description

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway.

Zelluna ASA

Country	Norway
Founded	2016
Industry	Biological Products, Except Diagnostic Substances
Employees	22
CEO	Namir Hassan

Contact Details

Address: Ullernchausséen 64 Oslo, 0379 Norway
Phone	47 22 84 00 80
Website	zelluna.com

Stock Details

Ticker Symbol	ZLNA
Exchange	Oslo Børs
Fiscal Year	January - December
Reporting Currency	NOK
SIC Code	2836

Key Executives

Name	Position
Namir Hassan	Chief Executive Officer
Hans Eid	Chief Financial Officer
Anders Holm	Chief Operating Officer